BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 6.05.1999

Immunotoxicity Testing Guidance; Availability

The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled ``Immunotoxicity Testing Guidance.'' This guidance is intended to provide FDA reviewers and manufacturers with a coherent strategy for assessing whether testing for potential adverse effects involving medical devices or constituent materials and the immune system is needed. The guidance is also intended to aid in developing a systematic approach to such testing.

Source: Federal Register — Food and Drug AdministrationOpen original release →